Weighted-Average Shares Outstanding (Diluted): The number of shares held by shareholders including insiders but not including a company's treasury shares assuming conversion of all convertible debt, securities, warrants and options, sourced from the company 10-K or 10-Q SEC reports.
Bone Biologics Corp. (BBLG) had Weighted-Average Shares Outstanding (Diluted) of 3.74M for the most recently reported fiscal quarter, ending 2026-09-30.
| Income Statement Financials | |
-- |
|
$-0.62M |
|
-- |
|
-- |
|
$0.67M |
|
$-0.67M |
|
$0.05M |
|
$-0.62M |
|
$-0.62M |
|
$-0.62M |
|
$-0.62M |
|
$-0.62M |
|
$-0.62M |
|
$-0.67M |
|
$-0.67M |
|
3.74M |
|
|
Weighted-Average Shares Outstanding (Diluted) |
3.74M |
$-0.17 |
|
$-0.17 |
|
| Balance Sheet Financials | |
$6.43M |
|
-- |
|
-- |
|
$6.43M |
|
$0.48M |
|
-- |
|
-- |
|
$0.48M |
|
$5.95M |
|
$5.95M |
|
$5.95M |
|
3.39M |
|
| Cash Flow Statement Financials | |
$-1.85M |
|
-- |
|
$2.61M |
|
$5.33M |
|
$6.09M |
|
$0.75M |
|
$0.04M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
13.38 |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
$-1.85M |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-10.38% |
|
-10.38% |
|
-9.60% |
|
-10.38% |
|
$1.76 |
|
$-0.50 |
|
$-0.50 |
|